Skip to main content
SpringerLink
Log in

Examination of changes in TGF-β1 and KL-6 expression over time in patients with chronic hepatitis C by AT-II receptor blocker therapy

  • Letters to the editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. R Bataller P Sancho-Bru P Gines JM Lora A Al-Garawi M Sole et al. (2003) ArticleTitleActivated human hepatic stellate cells express the renin–angiotensin system and synthesize angiotensin II Gastroenterology 125 117–25 Occurrence Handle10.1016/S0016-5085(03)00695-4 Occurrence Handle12851877

    Article  PubMed  Google Scholar 

  2. R Bataller P Gines JM Nicolas MN Gorbig E Garcia-Ramallo X Gasull et al. (2000) ArticleTitleAngiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 1149–56 Occurrence Handle10833490

    PubMed  Google Scholar 

  3. H Tsushima S Kawada S Tamura N Ito Y Shirai S Kiso et al. (1999) ArticleTitleReduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosis J Hepatol 30 1–7 Occurrence Handle10.1016/S0168-8278(99)80001-4

    Article  Google Scholar 

  4. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi T Nakatani et al. (2001) ArticleTitleAngiotensin-II type 1 receptor interaction is major regulator for liver fibrosis development in rats Hepatology 34 745–50 Occurrence Handle11584371

    PubMed  Google Scholar 

  5. Y Hirasawa N Kohno A Yokoyama Y Inoue M Abe K Hiwada (1997) ArticleTitleKL-6, a human MUC1 mucin, is chemotactic for human fibroblasts Am J Respir Cell Mol Biol 17 501–7 Occurrence Handle9376125

    PubMed  Google Scholar 

  6. K Suzuki H Takada S Oka S Kanouzawa M Iimuro Y Kitazumi et al. (2003) ArticleTitleClinical significance of KL-6, a marker of interstitial pneumonia, in cases of HCV-associated chronic liver disease Naika (Internal Medicine) 42 650–4

    Google Scholar 

  7. M Moriyama H Matsumura M Mikuni Y Arkawa S Ohshiro H Aoki et al. (2003) ArticleTitleThe clinical significance of serum KL-6 levels in patients with type C liver disease Hepatol Res 25 385–95 Occurrence Handle10.1016/S1386-6346(02)00307-8 Occurrence Handle12699849

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Geriatrics, Tokyo Women’s Medical University, 2-15-1 Shibuya, Shibuya-ku, Tokyo, 150-0002, Japan

    Takeshi Kurihara, Atsushi Maeda, Mutsuo Shigemoto & Katsuko Yamashita

Authors
  1. Takeshi Kurihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atsushi Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mutsuo Shigemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katsuko Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurihara, T., Maeda, A., Shigemoto, M. et al. Examination of changes in TGF-β1 and KL-6 expression over time in patients with chronic hepatitis C by AT-II receptor blocker therapy. J Gastroenterol 40, 855–856 (2005). https://doi.org/10.1007/s00535-004-1643-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-004-1643-z

Keywords

Search

Navigation